Clinical Trials
4 trialsNCT00023855 2019-12-13
PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT00008073 2013-12-19
Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
University of Pittsburgh
Phase 1 Completed
NCT00331955 2013-07-02
Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00079014 2013-05-16
3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed